Secondary Cancer Risks in Out-of-field Organs for 3-D Conformal Radiation Therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, Sungkoo | - |
dc.contributor.author | Kim, Seong Hoon | - |
dc.contributor.author | Kim, Chan Hyeong | - |
dc.contributor.author | Park, Jang Guen | - |
dc.contributor.author | Park, Jin Hyung | - |
dc.contributor.author | Jeong, Jong Hwi | - |
dc.date.accessioned | 2022-07-16T21:40:24Z | - |
dc.date.available | 2022-07-16T21:40:24Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2011-02 | - |
dc.identifier.issn | 2185-4823 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/168997 | - |
dc.description.abstract | The risk of secondary cancers after radiation therapy has become an important issue, mainly because advanced treatment techniques such as 3-D conformal radiation therapy (CRT) and intensity-modulated radiation therapy (IMRT) tend to increase the radiation dose to out-of-field organs. Moreover, cancer patients’ average survival period, following those advances in treatment techniques, also has increased, effectively raising the risks for the same levels of radiation exposure. In the present study, the secondary cancer risks to out-of-field organs were determined for some representative cases of 3-D CRT by measuring organ doses with LiF thermoluminescence (TL) dosimeters and an ATOMTM male phantom. Our results show that the secondary cancer risks are similar (difference: < 20%) for 6 and 10 MV X-ray beams for the same prostate treatment case. The total secondary cancer risks of the out-of-field organs were on the order of 2-4% for the treatment cases considered in the present study. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Atomic Energy Society of Japan | - |
dc.title | Secondary Cancer Risks in Out-of-field Organs for 3-D Conformal Radiation Therapy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Chan Hyeong | - |
dc.identifier.bibliographicCitation | Progress in nuclear science and technology, v.1, no. , pp.521 - 524 | - |
dc.relation.isPartOf | Progress in nuclear science and technology | - |
dc.citation.title | Progress in nuclear science and technology | - |
dc.citation.volume | 1 | - |
dc.citation.startPage | 521 | - |
dc.citation.endPage | 524 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordAuthor | secondary cancer risk | - |
dc.subject.keywordAuthor | 3-D conformal radiation therapy | - |
dc.subject.keywordAuthor | out-of-field organs | - |
dc.subject.keywordAuthor | anthropomorphic phantom | - |
dc.subject.keywordAuthor | TLD | - |
dc.identifier.url | http://www.aesj.or.jp/publication/pnst001/data/521.pdf | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.